Who is sponsoring NCT04316572?

NCT04316572 is sponsored by Heidelberg University.

What drugs are being tested in NCT04316572?

Interventions in NCT04316572: mental health specialist video consultation.

What condition does NCT04316572 study?

NCT04316572 studies Depression, Anxiety Disorder.

Is NCT04316572 still recruiting?

NCT04316572 is currently completed. Last updated 1 August 2023.

Last reviewed 2023-08-01 · How we verify

NCT04316572: PROVIDE-C

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Mental Health Specialist Video Consultations for Primary Care Patients

Completed NA Last updated 1 August 2023

What this trial tests

NA trial testing mental health specialist video consultation in Depression in 376 participants. Completed in 18 November 2022.

Timeline

24 March 2020

Primary endpoint
24 May 2022

18 November 2022

Quick facts

Lead sponsor	Heidelberg University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	health services research
Enrollment	376
Start date	24 March 2020
Primary completion	24 May 2022
Estimated completion	18 November 2022
Sites	1 location across Germany

Drugs / interventions tested

mental health specialist video consultation

Conditions studied

Depression — all drugs for Depression →
Anxiety Disorder — all drugs for Anxiety Disorder →

Sponsor

Heidelberg University

Who can join

18 and older, any sex, with Depression or Anxiety Disorder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Even in Western health care systems, most people with mental disorders, including those with severe and chronic disorders, are treated solely by their general practitioner (GP). Notably, the accessibility of mental health specialist care is mainly complicated by (a) long waiting times for specialists, (b) long travel distances to specialists, particularly in rural and remote areas, (c) patients' reservations about mental health specialist care (including fear of being stigmatised by seeking such care). To mitigate those barriers, technology-based integrated care models have been proposed. The purpose of this study is to measure the effectiveness of a mental health specialist video consultations model versus treatment as usual in patients with depression or anxiety disorders in primary care. In an individually randomized, prospective, two-arm superiority study with parallel group design, N = 320 patients with anxiety and/or depressive disorder will be recruited in GP practices.

Publications & conference data

7 peer-reviewed publications reference this trial (live from Europe PMC):

Mental Health Specialist Video Consultations Versus Treatment-as-Usual for Patients With Depression or Anxiety Disorders in Primary Care: Randomized Controlled Feasibility Trial.
Tönnies J, Hartmann M, Wensing M, Szecsenyi J, et al · · 2021 · cited 24× · PMID 33709931 · DOI 10.2196/22569
Mental health specialist video consultations versus treatment as usual in patients with depression or anxiety disorders in primary care: study protocol for an individually randomised superiority trial (the PROVIDE-C trial).
Haun MW, Tönnies J, Krisam R, Kronsteiner D, et al · · 2021 · cited 12× · PMID 33952313 · DOI 10.1186/s13063-021-05289-3
Intent to Adopt Video-Based Integrated Mental Health Care and the Characteristics of its Supporters: Mixed Methods Study Among General Practitioners Applying Diffusion of Innovations Theory.
Haun MW, Stephan I, Wensing M, Hartmann M, et al · · 2020 · cited 11× · PMID 33055058 · DOI 10.2196/23660
Model of integrated mental health video consultations for people with depression or anxiety in primary care (PROVIDE-C): assessor masked, multicentre, randomised controlled trial.
Haun MW, Tönnies J, Hartmann M, Wildenauer A, et al · · 2024 · cited 4× · PMID 39322237 · DOI 10.1136/bmj-2024-079921
Primary Care Physicians' Experiences with Integrated Mental Health Specialist Video Consultations-A Normalization Process Theory-Based Mixed-Methods Evaluation.
Müller S, Gagelmann L, Tönnies J, Wildenauer A, et al · · 2026 · PMID 41680544 · DOI 10.1007/s11606-025-10109-4
Engaging underrepresented patient groups in specialised treatment - qualitative results from the PROVIDE-C randomised trial on integrated mental health video consultations for depression and anxiety.
Müller S, Ritter-von Kramer A, Tönnies J, Wildenauer A, et al · · 2025 · PMID 41199204 · DOI 10.1186/s12889-025-25235-1
Mental health specialist video consultations versus treatment as usual in patients with depression or anxiety disorders in primary care: study protocol for an individually randomised superiority trial (the PROVIDE-C trial)
Haun MW, Tönnies J, Brinster R, Weber D, et al · · 2021 · DOI 10.21203/rs.3.rs-64848/v1

Verify or expand the search:

Other recruiting trials for Depression

Currently open trials in the same condition.

NCT07336238 — Group Retreat Psilocybin Therapy for the Treatment of Anxiety and Depression in Patients With Metastatic Solid Tumors or · Phase 2 · recruiting
NCT06906939 — A Randomized Pilot rTMS Trial for Knee Arthritis Pain and Depression · EARLY_PHASE1 · recruiting
NCT07517549 — Sexual Health Education During Pregnancy · NA · recruiting
NCT06408246 — ACE-D Aim 3 Clinical Cognitive Trial to Enhance Translation in Depression · Phase 2 · recruiting
NCT07449676 — Effects of an Innovative TCM-based Tui Jing Therapy on Psychological and Neurophysiological Functions in Depression · NA · recruiting

Other Heidelberg University trials

Trials by the same sponsor.

NCT07106294 — Hyperspectral Imaging for Prediction of Preeclampsia · recruiting
NCT06651164 — Psychosomatic Risk Screening · NA · completed
NCT07378345 — Optimization of Communication Between Surgery and Pathology · NA · completed
NCT06018272 — Mentalization-based Treatment Versus Bona-fide Treatment for Patients With Borderline Personality Disorder in Germany · NA · recruiting
NCT06852599 — Long-term Outcomes of Implants in Patients with Periodontitis · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04316572 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Heidelberg University
Last refreshed: 1 August 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04316572.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing